My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 566

    1.

    Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

    Kötter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Günaydin I, Grimbacher B, Blaschke S, Meyer-Riemann W, Peter HH, Stübiger N.

    Br J Ophthalmol. 2003 Apr;87(4):423-31.PMID: 12642304 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.

    Kötter I, Vonthein R, Zierhut M, Eckstein AK, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Stübiger N.

    Semin Arthritis Rheum. 2004 Apr;33(5):311-9.PMID: 15079762 [PubMed - indexed for MEDLINE]Related articles

    3.

    Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

    Kötter I, Zierhut M, Eckstein A, Vonthein R, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Kanz L, Stübiger N.

    Adv Exp Med Biol. 2003;528:521-3. No abstract available. PMID: 12918755 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.

    Kötter I, Eckstein AK, Stübiger N, Zierhut M.

    Br J Ophthalmol. 1998 May;82(5):488-94.PMID: 9713053 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a]

    Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N.

    Ophthalmologe. 2004 Feb;101(2):129-34. German. PMID: 14991308 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.

    Wechsler B, Bodaghi B, Huong DL, Fardeau C, Amoura Z, Cassoux N, Piette JC, LeHoang P.

    Ocul Immunol Inflamm. 2000 Dec;8(4):293-301.PMID: 11262659 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients]

    Stübiger N, Kötter I, Deuter C, Zierhut M.

    Klin Monbl Augenheilkd. 2001 Dec;218(12):768-73. German. PMID: 11805868 [PubMed - indexed for MEDLINE]Related articles

    8.

    Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a.

    Stübiger N, Besch D, Deuter CM, Zierhut M, Kötter I.

    Adv Exp Med Biol. 2003;528:529-32. No abstract available. PMID: 12918757 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.

    Bodaghi B, Gendron G, Wechsler B, Terrada C, Cassoux N, Huong du LT, Lemaitre C, Fradeau C, LeHoang P, Piette JC.

    Br J Ophthalmol. 2007 Mar;91(3):335-9. Epub 2006 Oct 18.PMID: 17050581 [PubMed - indexed for MEDLINE]Related articles

    10.

    Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

    Krause L, Altenburg A, Pleyer U, Köhler AK, Zouboulis CC, Foerster MH.

    J Rheumatol. 2008 May;35(5):896-903. Epub 2008 Apr 15.PMID: 18412306 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of Adamantiades-Behçet disease with systemic interferon alfa.

    Zouboulis CC, Orfanos CE.

    Arch Dermatol. 1998 Aug;134(8):1010-6.PMID: 9722733 [PubMed - indexed for MEDLINE]Related articles

    12.

    Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis.

    Plskova J, Greiner K, Forrester JV.

    Am J Ophthalmol. 2007 Jul;144(1):55-61.PMID: 17601428 [PubMed - indexed for MEDLINE]Related articles

    13.

    Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.

    Gueudry J, Wechsler B, Terrada C, Gendron G, Cassoux N, Fardeau C, Lehoang P, Piette JC, Bodaghi B.

    Am J Ophthalmol. 2008 Dec;146(6):837-44.e1.PMID: 19027420 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease.

    Guillaume-Czitrom S, Berger C, Pajot C, Bodaghi B, Wechsler B, Kone-Paut I.

    Rheumatology (Oxford). 2007 Oct;46(10):1570-3. Epub 2007 Aug 16.PMID: 17702770 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behçet's disease: a case report.

    Krause L, Hoffmann F, Zouboulis CC, Foerster MH.

    Graefes Arch Clin Exp Ophthalmol. 2003 Oct;241(10):871-4. Epub 2003 Sep 9.PMID: 13680252 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.

    Alpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O, Yazar S, Basaran E.

    Arch Dermatol. 2002 Apr;138(4):467-71.PMID: 11939808 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Interferon alfa-2a in the treatment of Behçet's disease.

    Azizlerli G, Sarica R, Köse A, Ovül C, Kavala M, Kayabali M, Erkan F, Kural Z.

    Dermatology. 1996;192(3):239-41.PMID: 8726638 [PubMed - indexed for MEDLINE]Related articles

    18.

    Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment.

    Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N.

    Adv Exp Med Biol. 2003;528:525-8. No abstract available. PMID: 12918756 [PubMed - indexed for MEDLINE]Related articles

    19.

    Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.

    Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.

    Jpn J Ophthalmol. 2007 May-Jun;51(3):191-6. Epub 2007 Jun 7.PMID: 17554481 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term effects of interferon alpha 2A treatment in Behçet's disease.

    Boyvat A, Sişman-Solak C, Gürler A.

    Dermatology. 2000;201(1):40-3.PMID: 10971058 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity